Related Experiment Video
Updated: Aug 11, 2026
MR Molecular Imaging of Prostate Cancer with a Small Molecular CLT1 Peptide Targeted Contrast Agent
Published on: September 3, 2013
Prostatic-specific antigen: clinical experience utilizing immunoperoxidase staining techniques in patients with
W C Baker1, F J Meyers, R W White
1Department of Urology, University of California, Davis School of Medicine, Sacramento 95817.
Abstract:
A human prostatic-specific antigen was first purified in 1979 by M.C. Wang et al. In the years to follow, investigators have been able to develop antisera to prostatic-specific antigen. Using an immunoperoxidase technique to stain both fresh and archival specimens, tissue of prostatic origin can be identified. The stain in our experience has been both specific and sensitive as an indicator of extraprostatic spread of carcinoma. We describe five cases where this technique has been useful in clinical practice.
